Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces the launch of the Prolaris + AI Test at the end of this month. Prolaris will be the ...

Next-generation sequencing is widely regarded as a transformative technology that delivers potentially life-prolonging therapies to patients with advanced cancers. Yet the testing is still underused ...

Genomic profiling can help personalize cancer care, but patients may not be offered these tests due to a burdensome ...

Researchers at University of California San Diego have developed a new artificial intelligence (AI) model that can translate ...

Researchers conducted a cross-sectional electronic survey to see whether respondents were offered and completed germline ...

In 2023, Jill Martin took a test that changed her life. She underwent genetic testing for breast cancer and learned she had a BRCA2 mutation, which increases one’s risk of developing breast and other ...

On-site automated NGS using circulating tumor DNA enabled comprehensive genomic testing in ~27 hours, substantially shortening the interval between diagnosis and potential targeted-therapy selection.

For the more than 300,000 women diagnosed with breast cancer each year, one of the biggest challenges is uncertainty around treatment options. Treatment isn’t one-size-fits-all and often comes with ...

Patient-centered education and navigation support increase consent rates for genomic testing, aiding integration into cancer care and access to genomics-based trials. The SURGE study underscores the ...

Health experts say testing can help doctors identify people who may benefit from earlier screenings, additional imaging, or ...

A new national pilot program will provide pancreatic cancer patients across Canada with free access to advanced genomic ...

CNW/ - Pancreatic Cancer North America (PCNA) is launching a new national pilot that will provide pancreatic cancer patients ...